Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009214
Chunk: 86

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 86
---
c) | any other reduction of share capital including without limitation the reduction                                                            
 of any share premium account of the Company, shall constitute a variation, modification or abrogation of the rights attaching to the B     
 Deferred Shares and the B Deferred Shares may at any time be cancelled (whether for no consideration or otherwise) by means of a reduction 
 of capital or repurchased in either case in accordance with the Act without the sanction or other consent of the holders of the B Deferred 
 Shares.                                                                                                                                    |

| (E) | Share certificates |

Notwithstanding any other provision
of the Articles and unless specifically required by the provisions of the Act, the Company shall not be required to issue any certificate
in respect of the B Deferred Shares.

| 144.2 | At any time after the adoption of these Articles: |

| (A) | The Company shall have irrevocable authority to appoint any person on behalf of                                                       
 any holder of B Deferred Shares to enter into an agreement to transfer such B Deferred Shares to such other person (whether or not an 
 officer of the Company) as the Board may determine to act as the custodian thereof; and/or                                            |

| (B) | The Board may convene a general meeting of the Company in accordance with Section                                                            
 694 of the Act, for the purpose of considering and, if thought fit, passing a resolution to authorise the terms of a contract for the        
 purchase by the Company of any or all of the B Deferred Shares. The terms of such contract shall provide for payment in full of the purchase 
 price upon completion and may require the holders of the B Deferred Shares concerned to sell such shares for a price not exceeding 1 penny   
 for all the B Deferred Shares so purchased. If such a resolution is passed and the Company is in all other respects able and willing to      
 purchase the B Deferred Shares to which the contract relates in accordance with Sections 690 to 708 of the Act, the Company shall have       
 irrevocable authority to appoint any person: (i) to execute such contract on behalf of each of the holders of the relevant B Deferred        
 Shares; (ii) to execute a stock transfer form (or forms) sufficient in every respect to transfer to the Company the legal title to the       
 B Deferred Shares that are the subject of such contract, and (iii) to receive at completion the purchase price on behalf of the holders      
 of the B Deferred Shares. From the time that such resolution is passed, the holders of the B Deferred